Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche invests in Spanish genome project

November 27, 2009
Research and Development Roche, Spain, genomics

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …

News

Tamiflu windfall helps Roche to bumper sales growth

October 15, 2009
Sales and Marketing Roche, Tamiflu

 Roche has raised its sales growth prediction for 2009 on the back of a strong third quarter and record sales …

News

Roche divests protein expression portfolio

September 10, 2009
Research and Development Roche, genomics

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …

News

Roche and PTC sign CNS research deal

September 4, 2009
Research and Development CNS, Roche

 PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …

News

Roche’s MabThera expands licence in leukaemia

September 4, 2009
Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

News

Avastin shows promise in advanced breast cancer

August 20, 2009
Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …

News

Avastin gets US approval in kidney cancer

August 4, 2009
Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

News

Roche strengthened by swine flu

July 29, 2009
Sales and Marketing Roche

The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …

News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009
Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …

News

Roche’s ABPI exit – a deliberate snub?

July 3, 2009
Research and Development, Sales and Marketing ABPI, Roche

 By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …

News

Roche quits ABPI

June 30, 2009
Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

News
Genentechlr

Genentech forms type I diabetes collaboration

June 11, 2009
Research and Development Roche, diabetes

 The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …

News

Roche aims to prove life-saving benefits of aleglitazar

June 10, 2009
Research and Development Roche, diabetes

News

RMG wins preferred supplier status

May 12, 2009
Manufacturing and Production Roche

News

Avastin fails in colon cancer study

April 30, 2009
Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …

News
The Gateway to Local Adoption Series

Latest content

A community-first future: which pathways will get us there?

November 21, 2025

Scitech Engineering joins Ekium Group, rebrands as Scitech-EKIUM

November 21, 2025

M42 and Olive Rock agree ownership of UAE health assets

November 20, 2025

iZafe Group signs agreement with Skand for automated medication dispenser

November 20, 2025

BioNet receives positive EMA opinion on new pertussis vaccine

November 19, 2025